SGX Pharmaceuticals, Inc. is an active Californian business entity incorporated 20th July 1999. National Registered Agents, Inc. acts as the agent for this company.
Company Data
| Company Name | SGX Pharmaceuticals, Inc. |
|---|---|
| Company Agent | National Registered Agents, Inc. |
| Company Status | Active |
| Entity Number | 2170559 |
| Entity Type | Stock Corporation - Out of State - Stock |
| Jurisdiction | Delaware |
| Incorporation Date | 20 July 1999 (24 years, 9 months ago) |
| Statement of Info | Due 31 July 2024 |
Principal Address
| Address | Lilly Corporate Center Indianapolis, IN 46285 |
|---|---|
| Map |
Mailing Address
| Address | Lilly Corporate Center Dc1094 Indianapolis,In46225 |
|---|---|
| Map |
Agent
| Agent Details | 1505 Corporation National Registered Agents, Inc. |
|---|
History
| 31 July 2023 | Statement of Information BA20231195263
| |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 25 July 2022 | Statement of Information BA20220561754
| |||||||||
| 28 September 2021 | System Amendment - SI Delinquency for the year of 0 LBA4747025 | |||||||||
| 25 March 2015 | System Amendment - Penalty Certification - SI LBA4747023
| |||||||||
| 7 October 2014 | System Amendment - SI Delinquency for the year of 0 LBA4747022 | |||||||||
| 25 June 2008 | Publicly Traded Corporate Disclosure Statement LBA4747021
| |||||||||
| 31 May 2007 | Publicly Traded Corporate Disclosure Statement LBA4747020
| |||||||||
| 27 November 2006 | Publicly Traded Corporate Disclosure Statement LBA4747019
| |||||||||
| 31 August 2006 | System Amendment - SI Delinquency for the year of 0 LBA4747018 | |||||||||
| 28 September 2005 | Amendment LBA4747017
| |||||||||
| 6 April 2001 | System Amendment - Penalty Certification - SI LBA4747016
| |||||||||
| 5 December 2000 | System Amendment - SI Delinquency for the year of 0 LBA4747015 | |||||||||
| 5 January 2000 | Amendment LBA4747014
| |||||||||
| 20 July 1999 | Initial Filing 2170559 |
This page was last updated October 2023.